Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date11/2012

General Information

Offices

Cambridge, USA
One Kendall Square, Ste. B6101
Cambridge, MA, 02139
USA

People

Founder
Board of Directors
Board of Directors

Funding

Tags

Pervasis Therapeutics Closed down November 14, 2012

Pervasis Therapeutics

Pervasis Therapeutics is a clinical stage company developing a broad portfolio of biologically active therapeutics. Building on its deep understanding of the specialized role that the endothelium plays in regulating natural healing and repair processes associated with disease, Pervasis is advancing groundbreaking new therapies to dramatically improve the outcomes of common vascular interventions, such as arteriovenous access, angioplasties, stents, and peripheral and coronary bypass grafts – the failure of which result in serious complications and a significant increase in medical costs.

Recent Milestones

Videos

Screenshots

Pervasis Therapeutics screenshot
Above: Pervasis Therapeutics
Uploaded: 10/16/09

Sources

  1. EDGAR [edit]
  2. Pervasis Therapeutics Closes Additional $9.75 Million in Financing (pervasistx.com) [edit]
  3. Pervasis Therapeutics Announces $17 Million in Financing and New Board Member (news.prnewswire.com) [edit]
  4. Pervasis broadens to cancer therapeutics, eyes new financings (masshightech.com) [edit]
    Pervasis hemodialysis treatment lands FDA fast-track review (masshightech.com) [edit]
    Pervasis drug candidate gets EU orphan drug status (masshightech.com) [edit]
Edit This Page
Last Edited 12/26/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy